Posted in | News

Kokam Awarded Contract to Construct 13MWh Energy Storage System in South Korea

Kokam Co., Ltd, the world's premier provider of innovative battery solutions, today announced that South Korea's largest utility, Korea Electric Power Corporation (KEPCO) (NYSE: KEP), has awarded it a contract to develop a 36-megawatt (MW) system / 13-megawatt hour (MWh) Energy Storage System (ESS) for frequency regulation at the Non-Gong substation in South Korea.

The project features a combination of two unique Kokam Lithium Ion battery technologies -- its Ultra High Power Nickel Manganese Cobalt (NMC) battery technology and its NANO battery technology. Work on the project began in June 2016 and is scheduled to be completed by December of 2016.

In March, Kokam announced that it had successfully deployed for KEPCO two Ultra High Power NMC ESSs -- a 24 MW system / 9 MWh and a 16 MW / 6 MWh system -- along with a 16MW / 5MWh Lithium Titanate Oxide (LTO) system. Together these systems currently provide KEPCO with 56 MW of energy storage capacity for frequency regulation. When the new 36 MW ESS project is completed, Kokam will have deployed 92 MW of energy storage capacity for frequency regulation for KEPCO, and the total worldwide capacity of ESSs using Kokam batteries will total 132 MW.

"We look forward to deploying this new 36 MW ESS for KEPCO and continuing to support its effort to install 500 MW of energy storage capacity for frequency regulation by the end of 2017," said Ike Hong, vice president of Kokam's Power Solutions Division. "Based on our advanced Ultra High Power NMC and NANO battery technologies, this ESS will provide KEPCO with the industry-leading performance, reliability and cycle life characteristics that they have come to expect from Kokam, enabling them to achieve a strong return on their energy storage investment."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.